May 13, 2019

New Insights into Treatment Targets for Men with Advanced Prostate Cancers

In the largest study of its kind, more than half of patients with advanced prostate cancers appear to be strong candidates for targeted cancer therapies

Apr 08, 2019

Huntsman Cancer Institute Announces Interim Clinical Leaders

Two physicians at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) are stepping into interim clinical leadership roles.

Mar 12, 2019

Huntsman Translational Scholars: Matthew Poppe, MD

Huntsman Cancer Institute (HCI) has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Translational researchers extend basic discoveries made in the laboratory and apply them to solve clinical problems and benefit patients through new diagnostic and therapeutic approaches.

Mar 04, 2019

Promising New Pancreatic Cancer Treatment Moves Forward

A study published today in the journal Nature Medicine led by researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) describes a new therapeutic approach with potential for patients with pancreatic cancer. These researchers discovered a combination drug therapy that may effectively combat the disease. HCI researchers first observed anti-cancer impacts in a laboratory setting and, subsequently, in its first use in a human patient.

Mar 01, 2019

Exercise for Improved Outcomes

The Precision Exercise Prescription study is a unique collaboration between medical doctors, researchers, physical therapists, and patients. The study looks at how an exercise program tailored for each patient can improve long-term outcomes after lung cancer surgery.

Mar 01, 2019

Together We Care Compassionately

Approximately 500 patients visit the outpatient clinics and infusion center at Huntsman Cancer Institute each day. Our patients rely on our clinical teams and staff to provide safe, efficient, and high quality care during each clinic visit. In this letter from Don Milligan, director of outpatient services, highlights recent efforts to provide the best care possible.

Mar 01, 2019

Clinical Trials: A Look at Recent Progress

Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ways to prevent, diagnose, or treat cancer. At any given time, Huntsman Cancer Institute has an average of 200 clinical trials open to cancer patients.

Mar 01, 2019

Pancreas Discovery Moves from Lab to Clinic

In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that had not been used in combination before to treat pancreatic tumors. The results were promising and they were able to move from the lab to clinical trial quickly. A clinical trial to test the safety and effect of this drug combination in pancreatic cancer is now underway at HCI and planned at other sites around the United States.